Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Ferraro

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Advances in Experimental Medicine and Biology|November 13, 2019
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in CancerStefania Morganti, Paolo Tarantino, Emanuela Ferraro, et al.
Cancer Treatment Reviews|June 29, 2026
Treatment of breast cancer brain metastases in the era of novel drugsJulian David Etessami, Giovanni Dalla Via, Emanuela Ferraro, et al.
Current Opinion in Oncology|August 22, 2022
Postneoadjuvant treatment for triple-negative breast cancerDario Trapani, Emanuela Ferraro, Federica Giugliano, et al.
Medicine|March 1, 2018
Never too old to fight breast cancer: A case reportMonica Zuradelli, Giovanna Masci, Emanuela Ferraro, et al.
Oncology Research and Treatment|April 1, 2016
Long-Lasting Stent Placement in an Elderly Advanced Ovarian Cancer PatientRaffaella Corvino, Francesca De Iuliis, Debora D'Aniello, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A reviewLuca Mazzarella, Bruno Achutti Duso, Dario Trapani, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real lifeStefania Morganti, Paolo Tarantino, Emanuela Ferraro, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Opportunities and challenges of implementing Pharmacogenomics in cancer drug developmentPaolo Tarantino, Dario Trapani, Stefania Morganti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2024
Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomesSonya M Chew, Emanuela Ferraro, Anton Safonov, et al.
Cancer Drug Resistance (Alhambra, Calif.)|January 11, 2023
Loss of HER2 in breast cancer: biological mechanisms and technical pitfallsStefania Morganti, Mariia Ivanova, Emanuela Ferraro, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|November 13, 2019
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in CancerStefania Morganti, Paolo Tarantino, Emanuela Ferraro, et al.
Cancer Treatment Reviews|June 29, 2026
Treatment of breast cancer brain metastases in the era of novel drugsJulian David Etessami, Giovanni Dalla Via, Emanuela Ferraro, et al.
Current Opinion in Oncology|August 22, 2022
Postneoadjuvant treatment for triple-negative breast cancerDario Trapani, Emanuela Ferraro, Federica Giugliano, et al.
Medicine|March 1, 2018
Never too old to fight breast cancer: A case reportMonica Zuradelli, Giovanna Masci, Emanuela Ferraro, et al.
Oncology Research and Treatment|April 1, 2016
Long-Lasting Stent Placement in an Elderly Advanced Ovarian Cancer PatientRaffaella Corvino, Francesca De Iuliis, Debora D'Aniello, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A reviewLuca Mazzarella, Bruno Achutti Duso, Dario Trapani, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real lifeStefania Morganti, Paolo Tarantino, Emanuela Ferraro, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Opportunities and challenges of implementing Pharmacogenomics in cancer drug developmentPaolo Tarantino, Dario Trapani, Stefania Morganti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2024
Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomesSonya M Chew, Emanuela Ferraro, Anton Safonov, et al.
Cancer Drug Resistance (Alhambra, Calif.)|January 11, 2023
Loss of HER2 in breast cancer: biological mechanisms and technical pitfallsStefania Morganti, Mariia Ivanova, Emanuela Ferraro, et al.
Pageof 4